NeoPhore is based in Altrincham, Cheshire, United Kingdom. It has raised $40M in total funding. Latest round: Series B.
NeoPhore funding overview
NeoPhore is based in Altrincham, Cheshire, United Kingdom. NeoPhore has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in December 2024. The round record for NeoPhore runs through 2024; nothing later has been disclosed. Investors on record include CPF managed by Sixth Element Capital, Claris Ventures, Astellas Venture Management, 3B Future Health Fund, 2investAG, NEVA SGR and 3 others. 9 distinct backers are named across the disclosed rounds.
NeoPhore at a glance
Total raised
$40M
Latest round
Series B
Latest round date
December 2024
Headquarters
Altrincham, Cheshire, United Kingdom
Notable investors
CPF managed by Sixth Element Capital, Claris Ventures, Astellas Venture Management, 3B Future Health Fund, 2investAG, NEVA SGR, LIFTT, Simon Fiduciaria
Frequently asked about NeoPhore funding
How much has NeoPhore raised?
NeoPhore has raised $40M in total disclosed funding across the rounds on record.
Who has invested in NeoPhore?
CPF managed by Sixth Element Capital, Claris Ventures, Astellas Venture Management, 3B Future Health Fund, 2investAG, NEVA SGR are named among the investors backing NeoPhore.
What was the latest NeoPhore funding round?
The most recent disclosed round is a Series B, announced in December 2024.
Where is NeoPhore based?
NeoPhore is based in Altrincham, Cheshire, United Kingdom.
When did NeoPhore last raise?
The last disclosed NeoPhore round closed in December 2024 at Series B.
Totals shown for NeoPhore aggregate every disclosed round on file. To see how that compares, browse the companies in Altrincham and the investors behind them below.
